Duality Advisers LP Has $715,000 Stock Holdings in Integer Holdings Co. (NYSE:ITGR)

Duality Advisers LP trimmed its stake in shares of Integer Holdings Co. (NYSE:ITGRFree Report) by 16.8% in the fourth quarter, Holdings Channel.com reports. The firm owned 7,221 shares of the medical equipment provider’s stock after selling 1,460 shares during the quarter. Duality Advisers LP’s holdings in Integer were worth $715,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in the stock. Handelsbanken Fonder AB increased its position in Integer by 1.7% during the 4th quarter. Handelsbanken Fonder AB now owns 5,837 shares of the medical equipment provider’s stock worth $578,000 after purchasing an additional 100 shares in the last quarter. abrdn plc grew its holdings in Integer by 0.6% during the 4th quarter. abrdn plc now owns 520,646 shares of the medical equipment provider’s stock worth $51,586,000 after acquiring an additional 3,013 shares during the last quarter. Knights of Columbus Asset Advisors LLC grew its holdings in Integer by 94.6% during the 4th quarter. Knights of Columbus Asset Advisors LLC now owns 48,082 shares of the medical equipment provider’s stock worth $4,764,000 after acquiring an additional 23,370 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in Integer by 16.8% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 5,724 shares of the medical equipment provider’s stock worth $567,000 after acquiring an additional 822 shares during the last quarter. Finally, Mackenzie Financial Corp bought a new stake in Integer during the 4th quarter worth approximately $204,000. 99.29% of the stock is currently owned by institutional investors and hedge funds.

Integer Stock Up 4.6 %

Shares of NYSE ITGR opened at $123.34 on Thursday. The firm has a market cap of $4.13 billion, a PE ratio of 45.85, a P/E/G ratio of 1.63 and a beta of 1.10. Integer Holdings Co. has a 12-month low of $69.40 and a 12-month high of $123.99. The company’s fifty day simple moving average is $112.68 and its 200 day simple moving average is $99.49. The company has a quick ratio of 1.71, a current ratio of 2.80 and a debt-to-equity ratio of 0.64.

Integer (NYSE:ITGRGet Free Report) last issued its earnings results on Thursday, February 15th. The medical equipment provider reported $1.39 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.34 by $0.05. The business had revenue of $413.15 million for the quarter, compared to analyst estimates of $409.04 million. Integer had a net margin of 5.68% and a return on equity of 10.80%. Integer’s revenue was up 10.9% on a year-over-year basis. During the same period in the prior year, the firm earned $1.11 earnings per share. As a group, sell-side analysts forecast that Integer Holdings Co. will post 5.31 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on ITGR. KeyCorp boosted their target price on shares of Integer from $123.00 to $139.00 and gave the stock an “overweight” rating in a report on Tuesday, April 9th. Benchmark upped their price objective on shares of Integer from $105.00 to $130.00 and gave the company a “buy” rating in a research note on Thursday, March 28th. CL King assumed coverage on shares of Integer in a research note on Thursday, March 14th. They issued a “buy” rating and a $137.00 price objective on the stock. Finally, Bank of America raised shares of Integer from a “neutral” rating to a “buy” rating and upped their price objective for the company from $105.00 to $135.00 in a research note on Monday, April 15th. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat, Integer presently has an average rating of “Moderate Buy” and an average target price of $120.50.

Get Our Latest Report on Integer

Integer Profile

(Free Report)

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.

Featured Stories

Want to see what other hedge funds are holding ITGR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Integer Holdings Co. (NYSE:ITGRFree Report).

Institutional Ownership by Quarter for Integer (NYSE:ITGR)

Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.